Posted by Michael Wonder on 21 Jun 2018
Australian Stage 3 melanoma patients forced to self-fund recurrent treatment while PBS makes decision on listing
21 June 2018 - An Australian man has described the staggering decision to pay $100,000 for a treatment that could mean life or death.
The news comes as patients struggle to afford prevention treatment while regulators battle to keep up with the latest in breakthrough cancer research.
Peter Gourlay was initially diagnosed in 2014 after the discovery of a melanoma on his back. Then, in September 2017, the 66-year-old marriage celebrant found a “worrying large” lump under his arm that was diagnosed as a Stage 3 metastatic melanoma.
